Cargando…
Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
PURPOSE: Prostate cancer with median lobe hyperplasia (MLH) is a relative contraindication for permanent prostate brachytherapy (PPB) because of an increased risk of post-implant dysuria and technical difficulties associated with achieving stability while implanting within the intravesical tissue. W...
Autores principales: | Muraki, Koichiro, Hattori, Chikayuki, Ogo, Etsuyo, Suefuji, Hiroaki, Eto, Hidehiro, Tsuji, Chiyoko, Miyata, Yusaku, Abe, Toshi, Chikui, Katsuaki, Nakiri, Makoto, Igawa, Tsukasa, Kakuma, Tatsuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170528/ https://www.ncbi.nlm.nih.gov/pubmed/34122564 http://dx.doi.org/10.5114/jcb.2021.105944 |
Ejemplares similares
-
Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: a single-institution review in Japan
por: Nakiri, Makoto, et al.
Publicado: (2022) -
Seed lost to perineum from hydrogel spacer after brachytherapy for prostate cancer
por: Nakiri, Makoto, et al.
Publicado: (2023) -
Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Nakiri, Makoto, et al.
Publicado: (2022) -
Organ preservation following radiation therapy and concurrent intra‐arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long‐term clinical results from a pilot study
por: Ono, Takeharu, et al.
Publicado: (2020) -
Dynamics in the expression of programmed death ligand 1 and cluster of differentiation 163 in the tumor microenvironment of uterine cervical cancer: a single-center retrospective study
por: Miyata, Yusaku, et al.
Publicado: (2023)